Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Operating expenses
Research and development expenses, net of government assistance	$ (585)	$ (1,286)	$ (1,054)	$ (3,042)
General and administrative expenses	(2,957)	(1,324)	(5,633)	(2,973)
Sales and marketing expenses	(25)	(134)	(25)	(850)
Impairment of intangible assets	0	(3,706)	0	(3,706)
Impairment of equipment		(1,584)		(1,584)
Loss from operating activities	(3,567)	(8,034)	(6,712)	(12,155)
Financial income (expenses)	4,548	1,888	4,575	1,343
Net income (loss) and total comprehensive loss	$ 981	$ (6,146)	$ (2,137)	$ (10,812)
Basic and diluted income (loss) per share (in dollars per share)	$ 0.03	$ (0.52)	$ (0.13)	$ (0.93)
Weighted average number of shares outstanding (in shares)	32,788,275	11,889,941	29,436,032	11,614,716